BCCQ SEC filings, in plain English
Everything Bleichroeder Acquisition III has filed with the SEC that we hold — 32 filings, newest first, 30 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: Bleichroeder Acquisition Corp. III filed Form 425 to disclose a communication regarding the proposed business combination with Mach X and Ursa Major, identifying participants in the proxy solicitation and outlining forward-looking statements and risk factors. Why it matters: This filing confirms the procedural steps for the merger vote and alerts investors to the specific risks cited by management, such as the potential for shareholder redemptions reducing liquidity or the inability to complete the deal by the July 7, 2028 deadline.
What changed: Bleichroeder Acquisition Corp. III filed a Section 425 communication announcing that the definitive proxy statement/prospectus regarding the business combination with Mach X and Ursa Major will be mailed to shareholders after the Registration Statement is declared effective. Why it matters: Investors tracking redemption deadlines should note the filing confirms the upcoming shareholder vote and distribution of definitive materials, though no specific redemption date or trust value changes are detailed in this preliminary notice.
What changed: Bleichroeder Acquisition Corp. III filed Form 425 to disclose a communication regarding the proposed business combination with Mach X and Ursa Major, which will serve as part of the proxy statement/prospectus for shareholder voting. Why it matters: This filing initiates the formal solicitation process for shareholders to vote on the merger, signaling that the deal is advancing toward completion despite the July 2028 redemption deadline.
What changed: Bleichroeder Acquisition Corp. III filed a Rule 425 communication stating the business combination with Ursa Major Technologies is supported by at least $350 million in equity commitments, including approximately $110 million funded upon signing and up to $345 million in additional proceeds depending on redemptions. The SPAC will be renamed Inflection Point Mach X Bleichroeder Corp., and management expects to receive the initial $110 million in weeks. Why it matters: Investors should note that the final PIPE amount of up to $345 million is contingent on shareholder redemptions, directly impacting the post-combination cash position and dilution; the filing also confirms the new entity name and domestication to Delaware prior to closing.
What changed: Bleichroeder Acquisition Corp. III filed a Section 425 communication announcing that the definitive proxy statement/prospectus for its business combination with Mach X and Ursa Major will be mailed to shareholders after the Registration Statement is declared effective, while disclosing forward-looking statements regarding the missiles and munitions market size and projected missile production. Why it matters: Investors should note that the filing explicitly lists the risk that the Business Combination may not be completed by the SPAC's initial business combination deadline of July 7, 2028, highlighting execution risks beyond standard redemption deadlines.
What changed: Bleichroeder Acquisition Corp. III filed Form 425 to disseminate a communication regarding the proposed business combination with Mach X and Ursa Major, which will serve as both a proxy statement for Mach X shareholders and a prospectus for securities issued in the transaction. Why it matters: This filing initiates the formal solicitation of proxies from Mach X shareholders to approve the Business Combination, marking a critical procedural step toward closing the deal before the SPAC's July 7, 2028 deadline.
What changed: The filing is a Form 425 communication regarding the proposed Business Combination between Mach X and Ursa Major, filed by Bleichroeder Acquisition Corp. III (BCCQ). It announces that a definitive proxy statement/prospectus will be mailed to Mach X shareholders after the Registration Statement is declared effective. The document contains standard legal disclaimers identifying participants in the solicitation (Mach X directors/officers and Ursa Major directors/officers/employees) and lists extensive risk factors related to the combination, including the risk of missing BCCQ's initial business combination deadline on 2028-07-07, potential shareholder redemptions, regulatory approvals, and operational risks for Ursa Major such as test failures or contract protests. No specific financial figures, redemption prices, or new deal terms are provided in this text; it serves as a notice of upcoming documentation. Why it matters: This filing confirms the procedural next step in the BCCQ-Ursa Major/Mach X transaction: the imminent distribution of definitive voting materials to SPAC shareholders. For investors tracking redemption deadlines, it reinforces that the 2028-07-07 deadline remains a critical constraint cited in the risk factors, though no immediate vote date is set. It alerts investors to review the forthcoming Registration Statement and Proxy Statement for material changes to valuation, sponsor conduct details, or specific redemption mechanics, as this current text contains only forward-looking statements and risk disclosures without binding commercial terms.
What changed: The filing is a Form 425 communication announcing that the definitive proxy statement/prospectus for the business combination between Mach X and Ursa Major, facilitated by SPAC Bleichroeder Acquisition Corp. III, will be mailed to Mach X shareholders after the Registration Statement is declared effective. It identifies participants in the solicitation (Mach X and Ursa Major management/directors) and lists forward-looking statements and risk factors regarding the deal, including potential redemptions, regulatory approvals, and operational risks for Ursa Major. Why it matters: This document serves as the primary informational notice to investors regarding the upcoming vote on the merger, detailing the timeline for receiving definitive materials and outlining the specific risks and forward-looking claims made by the companies' management that investors must consider before voting or deciding whether to redeem their shares.
What changed: The filing is a Form 425 containing a transcript of an investor webcast announcing the business combination agreement between Ursa Major Technologies, Inc. and Inflection Point Mach 10 (the SPAC). The document details that the combined company will trade on NASDAQ under the ticker IPXX and expects completion in the first quarter of 2027. It provides specific financial projections from Ursa Major CEO Chris Bagnoletti: 2024 revenue was $18.5 million, 2025 revenue was $45 million, 2026 revenue is expected to be $100 million, and 2027 revenue is targeted at approximately $200 million. The transcript cites a near-term pipeline of about $2.8 billion and states current production capacity is around 8 Havoc missiles per year, scaling to 500 units per year with transaction proceeds. It also lists key customers including the US Navy, Air Force, BAE Systems, and RTX. Why it matters: This filing establishes the commercial narrative and financial targets for the proposed merger, providing investors with specific revenue growth trajectories and production scale-up plans that justify the valuation and strategic rationale. By attributing these figures to the CEO and management team, it highlights the operational milestones (such as flight tests and manufacturing capabilities) that the sponsor claims will drive future performance, while simultaneously outlining the risks associated with government contract awards and production execution.
What changed: Bleichroeder Acquisition Corp. III (BCCQ) filed Form 425 to announce a definitive business combination agreement with Ursa Major Technologies, Inc., which will rename the combined entity to Inflection Point Mach X Bleichroeder and trade on Nasdaq as IPXX. The filing discloses a pre-money equity valuation of approximately $1.6 billion and a post-transaction equity valuation of approximately $2.3 billion. It confirms at least $350 million in PIPE commitments, with approximately $110 million funded at signing, anchored by sponsor Inflection Point Asset Management. The transaction is expected to close in the first quarter of 2027, subject to shareholder and regulatory approvals. Why it matters: This filing establishes the financial terms and strategic direction for BCCQ's target, moving from a blank check company to an active defense manufacturer focused on hypersonics and solid rocket motors. The $350 million PIPE provides significant capital to scale production capabilities, directly impacting the trust value dynamics through potential redemptions (up to $345 million in additional proceeds may be retained depending on redemption levels). Investors should note the specific deadline of July 7, 2028, remains the final date for completing this business combination, and the closing timeline is projected for Q1 2027.
What changed: The filing is a Form 425 submitted by Bleichroeder Acquisition Corp. III (the SPAC) in connection with the proposed business combination with Ursa Major Technologies, Inc. The document contains internal employee communications and an email from CEO C Spag announcing that Ursa Major has signed a business combination agreement with Inflection Point Acquisition Corp., the SPAC sponsor. Key terms disclosed include a $1.6B pre-money valuation, a $350M PIPE commitment (with ~$110M available at signing), and a closing expected in Q1 2027. The SPAC will be renamed 'Inflection Point Mach X Bleichroeder Corp.' and domesticate as a Delaware corporation. The filing also includes standard forward-looking statements and risk factors regarding the transaction. Why it matters: This filing confirms the specific financial structure of the deal, including the significant pre-funding of the PIPE ($110M at signing) which the company claims mitigates redemption risk. It establishes the timeline for the de-SPAC process (signing now, closing Q1 2027) and identifies the new trading entity name. For investors, it provides the first public details on the valuation jump to $1.6B pre-money and the involvement of Inflection Point Asset Management, while the inclusion of internal emails highlights the material non-public information (MNPI) controls and the narrative being pushed to employees regarding customer confidence and operational continuity.
What changed: The filing is a Form 425 customer communication from Ursa Major Technologies, Inc. announcing that it has selected Inflection Point Mach X Bleichroeder Corp. (formerly Bleichroeder Acquisition Corp. III) as its SPAC merger partner, reversing prior expectations or competing processes. The communication states the transaction values Ursa Major at $2.3B post-money and provides at least $350M in committed capital, with an expected closing in Q1 2027. It confirms the SPAC will rename to 'Inflection Point Mach X Bleichroeder Corp.', domesticate from Cayman Islands to Delaware, and list on Nasdaq. The document also lists extensive forward-looking statements and risk factors regarding the business combination, including risks related to redemption requests, financing conditions, regulatory approvals, and operational performance of hypersonic systems. Why it matters: This filing confirms the specific target company (Ursa Major) and the commercial terms ($2.3B valuation, $350M capital) for Bleichroeder Acquisition III's pending business combination, which was previously only known by the SPAC name. It establishes the timeline for the de-SPAC transaction (Q1 2027) and highlights key risks for shareholders, particularly the potential impact of redemptions on liquidity and listing status, and the dependency on obtaining shareholder approval and financing. For investors tracking the deal, this provides the definitive public announcement of the merger partner and initial financial metrics, moving the event from speculation to announced execution phase.
What changed: Form 8-K Current Report and Rule 425 Written Communication announcing a Business Combination Agreement. FIRST, this document is a Form 8-K Current Report and Rule 425 Written Communication announcing a Business Combination Agreement. SECOND, reporting mechanics: The Business Combination Agreement establishes an Outside Date of August 24, 2027, with an automatic extension granting one calendar day per calendar day after October 31, 2026 for delayed financial statements, solely applicable to Ursa Major’s termination right, per the agreement. The Minimum Cash Condition requires that trust account cash (post-redemptions) plus aggregate gross Closing PIPE proceeds, less underwriting fees and transaction costs, equal or exceed $150,000,000, waivable solely by Ursa Major, as defined in the agreement. A Sponsor Support Agreement signed by Bleichroeder Sponsor 3 LLC and Inflection Point Fund I, LP mandates restricted holders vote for Transaction Proposals, waive anti-dilution rights on Cayman Class B Ordinary Share conversions, and oppose alternatives, per the sponsor support terms. Lock-Up Agreements restrict Sponsor Founder Shares for six months and Sponsor Warrants for 30 days, while Seller Lock-Up Agreements restrict seller securities for six months, per the lock-up agreements. THIRD, reporting substance: The Aggregate Consideration applies a purchase price of $1,600,000,000 divided by $10.00, which equates to 160,000,000 shares of New Ursa Major Common Stock, per the Business Combination Agreement. Forward-Looking Statements detail the target’s strategy around hypersonic systems, solid rocket motors, and in-space mobility solutions, alongside government contract funding dependencies and prime contractor relationships, per that section. Per Item 5.02, Michael Blitzer was appointed Chairman and Kevin Shannon was appointed Co-CEO effective August 24, 2026, with Andrew Gundlach and Marcello Padula continuing as director and Co-CEO respectively. The Closing PIPE Investment commits approximately $242.5 million for 20,208,328 Series A Preferred Stock shares at a $12.00 stated value, accruing 10.0% annual dividends if paid in kind or 8.0% if paid in cash, compounding semi-annually, per the Series A SPAs. A Pre-Funded PIPE Investment delivers approximately $107.5 million for 10,539,215 shares, per the other events section. Protective provisions require approval by holders of more than 50% of issued preferred stock for major actions, while permitting up to $50 million in asset-based financing and $30 million under a J.P. Morgan senior secured facility without consent, per the certificate of designation. Why it matters: This filing materially dictates deal viability by contractually securing sponsor and seller voting compliance, anchoring completion to a hard $150,000,000 net cash threshold that directly links public trust liquidity to transaction success, and structuring a multi-year outside date with conditional extensions. The combined PIPE capital of approximately $350,000,000 funds the $1,600,000,000 acquisition framework and structurally insulates against heavy redemptions. Leadership consolidation under Blitzer and Shannon signals active sponsor execution capacity, while the highly tiered equity structure (compound dividend accruals, dollar-priority liquidation preferences, and veto-capable protective provisions) introduces capitalization complexity that investors must stress-test against disclosed government procurement cycles, flight test execution risks, and supply chain dependencies.
outside datenothing moved · 1 with no prior record of ours
- Outside date
- not previously extracted2027-08-24
SpacBrain reads this as the agreement may be terminated from 2027-08-24.
The clause …“if any of the conditions to the Closing have not been satisfied or waived by August 24, 2027 (the “Outside Date”), subject to the limitations set forth in the Business Combination Agreement, including that the right to terminate on”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Bleichroeder Acquisition Corp. III (Mach X) filed a Form 8-K on August 25, 2026, reporting the entry into a Business Combination Agreement with Ursa Major Technologies, Inc. on August 24, 2026. The deal values Ursa Major at a Purchase Price of $1,600,000,000, resulting in the issuance of 160,000,000 shares of New Ursa Major Common Stock to Ursa Major shareholders. The transaction includes a Closing PIPE Investment of approximately $242.5 million for 20,208,328 shares of Series A Preferred Stock and warrants, and a Pre-Funded PIPE Investment of approximately $107.5 million by Inflection Point Fund I, LP and others. Mach X will domesticate from the Cayman Islands to Delaware. Michael Blitzer and Kevin Shannon were appointed Chairman and Co-CEO, respectively. The filing does not report any specific redemption deadline changes or trust value adjustments beyond the standard Minimum Cash Condition requiring $150,000,000 in post-redemption cash. Why it matters: This filing confirms the definitive terms of the merger between SPAC BCCQ and Ursa Major, establishing the $1.6 billion valuation and the structure of the equity consideration. It details significant PIPE financing ($350 million total) which supports the Minimum Cash Condition, reducing redemption risk if executed as planned. The appointment of new leadership (Blitzer/Shannon) signals a change in management control aligned with the Sponsor's other recent deals. Investors should note the complex capital structure involving Series A Preferred Stock with 10% dividends, put/call rights, and anti-dilution protections, as well as the domestication process which may trigger redemption rights for public shareholders.
outside datenothing moved · 1 with no prior record of ours
- Outside date
- not previously extracted2027-08-24
SpacBrain reads this as the agreement may be terminated from 2027-08-24.
The clause …“if any of the conditions to the Closing have not been satisfied or waived by August 24, 2027 (the “Outside Date”), subject to the limitations set forth in the Business Combination Agreement, including that the right to terminate on”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Quarterly report on Form 10-Q for Bleichroeder Acquisition Corp. III, a blank-check company that had just completed its IPO and had no operations during the period. This is the company's first 10-Q covering the period from inception (April 1, 2026) through June 30, 2026. The filing reports a net loss of $2,078,048, driven primarily by $2,015,750 in share-based compensation expense, and a shareholders' deficit of $37,298. Subsequent to the quarter, on July 8, 2026, the company closed its IPO of 34,500,000 units at $10.00 each, generating $345,000,000 in gross proceeds, which along with $8,500,000 from a private placement of warrants, was deposited into a trust account ($10.00 per public share). The trust is initially invested in U.S. government obligations. The company has 24 months (until July 2028) to complete a business combination. The filing reports no cash on hand as of June 30, 2026, but management asserts sufficient liquidity post-IPO. There is no redemption deadline, extension vote, or pending deal disclosed; the company is still searching. Why it matters: This filing establishes the baseline financial position and trust value for a newly-public SPAC. The trust holds exactly $10.00 per public share, the full $345 million from the IPO, giving investors a clear redemption floor. The significant share-based compensation expense in the pre-IPO period (related to founder shares granted to officers) is now in the rearview mirror. The disclosure of a $527,974 working capital deficit at June 30, 2026, which was alleviated by the IPO, highlights the sponsor's funding role. The company's stated focus is North American and European businesses in disruptive growth sectors. The absence of any business combination target or extension request means investors face a 24-month clock starting July 2026.
What changed: Form 8-K current report containing an attached press release announcing the authorization of separate trading for the registrant's unit components. Per the press release dated July 31, 2026, the registrant announced that commencing August 3, 2026, holders of units (each comprising one Class A ordinary share and one-fourth of one redeemable warrant) may elect to separate the components for independent trading. Upon separation, Class A ordinary shares (par value $0.0001 per share) will trade under symbol BCCQ and whole redeemable warrants (exercisable for one Class A ordinary share at an exercise price of $11.50 per share) will trade under symbol BCCQW. Unsold units continue under BCCQU. The filing specifies that no fractional warrants are issued during separation and instructs holders to coordinate with transfer agent Continental Stock Transfer & Trust Company through their brokers. Why it matters: This mechanical change to the capital structure enhances pre-merger liquidity and allows investors to manage equity exposure and warrant optionality independently, though it does not extend the redemption deadline, alter trust account mechanics, or signal advanced deal progress. The filing also provides substantive visibility into the sponsor's investment thesis, stating the company's primary focus is on North American and European businesses in disruptive growth sectors, specifically targets being transformed via technology adoption. The document identifies the operating team: Co-Founders Michel Combes and Andrew Gundlach, Chief Executive Officer Marcello Padula, Chief Financial Officer Robert Folino, and board members Clemence Rasigni, Christopher Kellen, and Constantine Dakolias. Contact for inquiries is directed to Robert Folino at 212.984.3835.
What changed: Form 8-K Current Report filed pursuant to Item 5.02 of Regulation S-K, serving as a routine regulatory notice of a board seat vacancy fill. On July 20, 2026, the Board of Directors appointed Constantine Dakolias as an independent director, effective immediately, and assigned him to the audit committee. According to the registrant's disclosure, Mr. Dakolias is age 60 and has over three decades of investment, credit, and asset management experience. The company states he spent nearly 25 years at Fortress Investment Group as Co-Chairman and previously Co-Chief Investment Officer of credit and real estate funds. Prior to Fortress, he co-founded and served as Managing Director of American Commercial Capital LLC and Coronado Advisors, which the filing notes were sold to Wells Fargo & Co. in 2001. He holds a B.S. in Physics from Columbia University. The filing does not report any modifications to the trust account balance, per-share redemption price, extension voting timeline, or pending business combination progress. Why it matters: Changing a board seat does not automatically reset redemption deadlines, adjust trust distribution calculations, or trigger mandatory extension filings. The addition of a director with credited real estate debt and credit fund management experience may signal the sponsor is tailoring governance depth toward sectors involving leverage or property portfolios ahead of a potential merger announcement. The document concurrently reaffirms the registrant's exchange registrations: BCCQU units comprise one Class A ordinary share ($0.0001 par value) and one-fourth of one redeemable warrant; each whole warrant carries a $11.50 exercise price for one Class A ordinary share. No operating metrics, partnership announcements, litigation exposures, or strategic realignments are disclosed.
What changed: A Schedule 13G beneficial ownership report accompanied by Exhibit 99.1, a Joint Filing Agreement dated July 14, 2026, submitted by CONTINENTAL GENERAL INSURANCE CO, Continental Insurance Group, Ltd., Continental General Holdings LLC, and Gorzynski Michael. The filing establishes a joint reporting framework for BCCQ units, defined in the document as each consisting of one Class A ordinary share and one-fourth of one redeemable warrant. Regarding mechanics, the exhibit discloses no modifications to the redemption deadline (2028-07-07), trust value per share, extension provisions, or the SPAC’s SEARCHING status; those parameters remain static relative to prior disclosures. With respect to other substance, the document contains no assertions regarding customers, revenue streams, total addressable market sizing, strategic pivots, proprietary technology, commercial partnerships, active litigation, or executive appointments. All execution authorities are attributed exclusively to Michael Gorzynski in his capacities as Executive Chairman, Chairman & President, Manager, and private individual. Why it matters: The joint filing fulfills Section 13(d) reporting requirements by consolidating the legal and administrative responsibility for the named entities and individual across their respective BCCQ positions. For investors monitoring redemption behavior, trust sufficiency, and sponsor conduct, the absence of breakpoint percentages, purchase dates, acquisition prices, or statement of purpose in this joint agreement means the precise economic scale or intent behind the holdings cannot be evaluated from this text alone. Nevertheless, the structured compliance by an insurance holding entity and named executives during the two-year pre-deadline window signals ongoing shareholder engagement and regulatory adherence, even as the operational milestones for a business combination remain undisclosed.
What changed: A Joint Filing Agreement attached to a Schedule 13G beneficial ownership report. The exhibit codifies a joint filing arrangement dated April 13, 2026 (submitted July 14, 2026) among Bleichroeder Sponsor 3 LLC, Andrew Gundlach, and Michel Combes for their combined beneficial ownership of Class A ordinary shares, $0.0001 par value, as of July 8, 2026. Each signing Party represents eligibility to file under Schedule 13G and accepts shared responsibility for the timeliness, completeness, and accuracy of the disclosure. The document contains no language modifying the redemption calendar, trust account composition, extension procedures, target acquisition status, or sponsor governance protocols. It also discloses no operational claims, customer relationships, revenue metrics, market sizing, technology roadmaps, partnership terms, litigation positions, or executive appointments. Why it matters: For investors tracking redemption deadlines and sponsor conduct, this filing functions as a routine regulatory coordination mechanism rather than a transactional catalyst. By establishing joint liability for the accuracy of the July 8, 2026 ownership baseline, it reduces the risk of fragmented or contradictory Schedule 13G submissions that could obscure aggregate sponsor exposure prior to the upcoming deadline. The absence of strategic commentary, financial data, or structural amendments confirms the entity remains in its search phase with no new deal progress, trust value fluctuations, or behavioral shifts introduced by the signatories. Consequently, redemption calculus and valuation parameters are unaffected, though the agreement ensures transparent, consolidated tracking of sponsor positioning through any required amendments.
What changed: Form 8-K current report and accompanying audited financial statements disclosing the July 8, 2026 consummation of Bleichroeder Acquisition Corp. III’s initial public offering, post-closing capitalization, sponsor arrangements, and standard blank-check governance provisions. According to the registrant’s management and audited balance sheet, the company closed its IPO on July 8, 2026, issuing 34,500,000 units at $10.00 per unit for $345,000,000 in gross proceeds, fully executing the underwriters’ 4,500,000-unit over-allotment option. Management reports $345,000,000 was deposited into a U.S.-based trust account at Continental Stock Transfer & Trust Company, establishing a per-unit trust value of $10.00. Simultaneously, the company sold 8,500,000 private placement warrants at $1.00 each for $8,500,000, with Bleichroeder Sponsor 3 LLC buying 5,000,000 and underwriters Cohen & Company Capital Markets and Clear Street LLC buying 3,500,000. The filing confirms a 24-month completion window for an initial business combination, triggers standard redemption mechanics at pro-rata trust value, and notes the sponsor waives redemption rights on founder shares while pledging indemnification if third-party claims reduce trust assets below the lesser of $10.00 per public share or actual liquidation value. Beyond these mechanics, the registrant discloses total transaction costs of $21,364,856 (split into a $6,000,000 cash underwriting fee, $14,700,000 deferred underwriting fee, and $664,856 other offering costs), operating cash of $1,467,629, and prepaid insurance of $195,668. Governance updates show 11,500,000 founder shares issued after removing a 1,500,000-share forfeiture contingency. Related-party arrangements approved by management include a $5,000 monthly administrative payment to the sponsor and a $600,000 advisory services contract through MJP Advisory Group, LLC (affiliated with Chief Executive Officer Marcello Padula), accruing $18,000 monthly before settling at business combination or liquidation. Why it matters: For investors tracking redemption calendars and trust preservation, the disclosure locks the trust floor at $345,000,000 with zero pre-deal distributions, confirming the baseline liquidity pool available for shareholder exits once operations begin. The 24-month operational timeframe starts precisely at the July 8, 2026 IPO close, defining the hard deadline before automatic liquidation protocols activate, though no extension mechanism or amendment to the completion window is introduced. The $14,700,000 deferred underwriting liability establishes a fixed structural deduction from trust balances upon deal closure or dissolution, directly modeling net proceeds to remaining equity. Sponsor conduct is transparently bounded: founder shares carry mandatory one-for-one conversion, redemption waivers apply to insiders, and the $600,000 plus $18,000 monthly advisory fee drains exclusively from the $1,467,629 outside-trust working capital, requiring executives to manage pre-combination burn rate without touching protected trust funds. Because the filing solely documents IPO settlement, audited pre-operation financials, and codified shell-company covenants, it does not shift existing public calendar dates or announce target selection, but it permanently anchors the trust composition, sponsor indemnity posture, and working-capital constraints that will govern all future deal-progress and redemption disclosures.
What changed: Form 8-K filed by Bleichroeder Acquisition Corp. III to report the completion of its initial public offering (IPO) and related organizational matters. The Company consummated its IPO of 34,500,000 units (including full exercise of the underwriters' over-allotment option) at $10.00 per unit, generating gross proceeds of $345,000,000. Simultaneously, it completed a private placement of 8,500,000 warrants to the Sponsor and Underwriters for $8,500,000. Total proceeds of $345,000,000 were deposited into the trust account. The trust's deadline for completing an initial business combination is 24 months from the IPO closing (July 8, 2028), unless extended by shareholders. The Company also appointed two new independent directors and amended its articles of association to, among other things, set the completion window and define shareholder redemption rights. Why it matters: This filing establishes the SPAC's baseline financial structure (a classic $10.00/share trust with a 24-month deadline) and governing mechanics. All future redemption deadlines, deal negotiations, and proxy statements will reference this founding trust amount, warrant terms, and the 24-month deadline. The document confirms standard SPAC mechanics: (1) the trust holds $10.00 per public share; (2) the 24-month countdown started July 8, 2026; (3) founder and sponsor securities are subject to standard lock-ups; (4) public shareholders have redemption rights in connection with a business combination or certain charter amendments; (5) the business combination must target net assets of at least 80% of the trust balance.
What changed: An initial public offering prospectus (Rule 424(b)(4)) filed by Bleichroeder Acquisition Corp. III for the proposed sale of 30,000,000 units at a public offering price of $10.00 per unit, generating gross proceeds of $300,000,000, alongside a concurrent private placement of 8,500,000 warrants at $1.00 per warrant. This filing formally establishes the trust mechanics, redemption calendar, and sponsor terms for a brand-new search-phase SPAC. Why it matters: The prospectus and management biographies assert a strategy targeting North American and European businesses in disruptive growth sectors transformed via technology adoption, citing the co-founders’ operational experience. The document attributes specific prior SPAC outcomes to the team: Bleichroeder Acquisition Corp. I closed its merger with Merlin Labs, Inc. on March 16, 2026, referencing a $105 million United States Special Operations Command contract and a U.S. Air Force agreement; Bleichroeder Acquisition Corp.
What changed: Routine compliance exhibit — SEC Form 3 initial statement of beneficial ownership of securities. According to the filing, director Clemence Rasigni reports zero non-derivative transactions or holdings. No insider purchases, sales, or transfers are recorded that would adjust the public share count, influence trust funding mechanics, alter redemption threshold calculations, or affect extension voting dynamics ahead of the 2028-07-07 deadline. Why it matters: A Form 3 establishes a director’s baseline reporting position upon appointment or role assumption. The filing explicitly states that no positions were recorded, providing investors with a null signal regarding board-level capital commitment during the searching phase. This does not mechanically impact the redemption calendar, trust value, or deal progression, but it documents the starting point for monitoring sponsor and director accumulation prior to target identification. The submission contains no operational, financial, technological, partnership, litigation, or personnel assertions beyond standard issuer and reporter metadata.
What changed: Form 3 — insider ownership report. Per the filing, Bleichroeder Sponsor 3 LLC, Gundlach Andrew, and Combes Michel are each identified as a 10% owner. The issuer explicitly states there were 'No non-derivative transactions or holdings reported.' Why it matters: This routine compliance exhibit confirms baseline insider equity positions during the SPAC’s SEARCHING phase. Regarding the mechanics you track, the document provides no updates on redemption deadlines, trust value, extension requests, target identification progress, or sponsor conduct. The absence of reported transfers indicates static sponsorship stakes, preserving the existing acquisition timeline and capital structure. Outside of insider positions, the filing contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel.
What changed: Form 3 – Initial Statement of Beneficial Ownership of Securities, specifically an insider ownership report filed by Chief Financial Officer Robert Folino for Bleichroeder Acquisition Corp. III. The filing explicitly states 'No non-derivative transactions or holdings reported.' Insider share counts and derivative positions remained unchanged at the time of filing, with zero purchases, sales, or grants recorded for the reporting officer. Why it matters: For SPAC mechanics, a transaction-free Form 3 confirms baseline executive positioning without capital infusion or liquidity drain. It indicates no officer purchases that would absorb public float or signal near-term merger readiness, nor sales that could trigger early redemptions or lock-up adjustments. With no transactional volume reported, the public trust balance faces no offsetting buy-sell pressure from insiders, and the SEARCHING status plus the 2028-07-07 deadline proceed without adjustment to capital structure or voting power. The document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel beyond standard regulatory metadata and executive identification.
What changed: A Form 3 initial beneficial ownership report filed by Chief Executive Officer Marcello J. Padula for Bleichroeder Acquisition Corp. III, disclosing no non-derivative transactions or holdings. As explicitly stated in the filing, reporting person Marcello J. Padula reported zero non-derivative equity transactions or holdings. The document does not adjust trust account mechanics, extend the business combination deadline, advance or postpone a target acquisition, or alter sponsor conduct protocols. Why it matters: This routine compliance exhibit establishes a baseline ownership snapshot for management without providing traction on the SEARCHING status, shareholder redemption triggers, or merger pipeline. Investors monitoring the redemption calendar, trust preservation, and deal progress should prioritize subsequent S-4 amendments, definitive proxy statements, and substantive Sections 16 filings over this administrative disclosure.
What changed: A Form 3 insider ownership report submitted to the SEC by director Christopher Kellen regarding his beneficial interests in Bleichroeder Acquisition Corp. III. The filing states that director Christopher Kellen reported 'No non-derivative transactions or holdings.' Because the submission records zero equity movements, it does not modify the SPAC redemption timeline, trust accounting, extension triggers, or acquisition pipeline. Per the document, director Christopher Kellen holds no reportable security positions at the time of filing. Why it matters: As a standard compliance exhibit, this filing tracks director adherence to SEC disclosure rules without conveying strategic signals about a target combination or liquidation pathway. Investors monitoring the redemption calendar or trust value receive no updated tactical data from director Christopher Kellen, nor do they observe sponsor behavior shifts linked to insider equity activity.
What changed: A Form 8-A for registration of certain classes of securities pursuant to Section 12(b) of the Securities Exchange Act of 1934, registering Units, Class A ordinary shares, and whole warrants exercisable for one Class A ordinary share each on The Nasdaq Stock Market LLC. Per the filer Bleichroeder Acquisition Corp. III, this filing registers the listed securities without modifying the stated trust value of $10 per share, the redemption deadline of 2028-07-07, or the SEARCHING status. Why it matters: By activating Nasdaq listing mechanics while leaving the $10 trust per share, 2028-07-07 deadline, and SEARCHING status intact, the filing dictates that redemption triggers and timeline management remain governed by prior S-1 terms rather than this registration. The $11.50 warrant strike and $0.0001 par value define capital structure economics per the registrant’s statements, but Padula and the company made zero claims regarding customers, revenue, market size, strategy, technology, partnerships, or litigation.
What changed: Registration Statement on Form S-1 for an initial public offering (IPO) of 30,000,000 units by Bleichroeder Acquisition Corp. III, a blank check company formed to effect a business combination. New SPAC filing; no prior public filings. Establishes IPO terms: $10 per unit, 24-month completion window, $300M trust, sponsor and underwriter purchase of 8.5M private placement warrants at $1 each, sponsor holds 11.5M founder shares at ~$0.002 each. No target selected. Management team's prior SPACs: BACQ completed Merlin Labs deal (March 2026); BBCQ announced Pasqal deal (expected H2 2026). Why it matters: First public disclosure of BCCQ's structure and terms. Provides redemption mechanics, trust size ($10.00 per share), deadline (24 months from closing, likely 2028), dilution from founder shares, sponsor incentives, and conflicts. Investors need this to evaluate the SPAC's risk/reward. Also details prior SPAC track record of management.
What changed: Confidential Draft Registration Statement on Form S-1 and preliminary prospectus for an initial public offering of 25,000,000 units. As detailed in the confidential Draft Registration Statement dated May 18, 2026, the company establishes a $250,000,000 trust ($287,500,000 if the underwriters exercise their over-allotment option in full), which the prospectus states is 'initially anticipated to be $10.00 per public share.' The filing specifies a 24-month completion window from closing, with a provision allowing shareholder-approved extensions capped at 36 months. Why it matters: According to the filing, these mechanics directly govern shareholder liquidity windows and redemption pricing relative to the trust balance, which the prospectus calculates could result in Adjusted NTBVPS ranging from $7.09 to $9.81 depending on redemption levels. The prospectus explicitly attributes dilution risks and conflict of interest warnings to the nominal founder share cost and the sponsor's $5,000,000 private placement commitment alongside $2,000,000 convertible working capital loan authority.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.